Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
China’s coronavirus test providers hit by payments crunch
Local governments’ failure to settle bills raises doubts on sustainability of zero-Covid policy
Source: FT.com - Drugs and Healthcare - November 16, 2022 Category: Pharmaceuticals Source Type: news
Renewing Covid's Status As A Public Health Emergency Was The Right Call. Here's Why
Public health law experts Lawrence Gostin and James Hodge explain the importance of the public health emergency declaration as Covid cases and hospitalizations begin to rise.
Source: Forbes.com Healthcare News - November 14, 2022 Category: Pharmaceuticals Authors: Lawrence Gostin, Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Policy /policy Coronavirus Editors' Pick editors-pick Source Type: news
TRIPS waiver expansion risks public health
The Biden administration and other World Trade Organization members are considering expanding the harmful and unnecessary waiver of intellectual property (IP) protections under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) beyond COVID-19 vaccines. These governments should approach this decision with a clear understanding of one of the most significant consequences of that action: compromised public health, especially in lower-income countries.
Source: The Catalyst - November 14, 2022 Category: Pharmaceuticals Authors: Megan Van Etten Tags: Intellectual Property Coronavirus TRIPS Waiver Source Type: news
Majestic Princess Cruise Ship With Over 800 Covid-19 Positive Passengers Docks In Australia
At least one in five got infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Source: Forbes.com Healthcare News - November 14, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Lifestyle /lifestyle Travel /travel business pharma Source Type: news
What ’s A Tripledemic? RSV, Covid, And Flu—Oh, My
A new surge in three viruses is leading to rise in hospitalizations in children, even before winter hits. This "tripledemic" is something we've never seen.
Source: Forbes.com Healthcare News - November 12, 2022 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Tags: Healthcare /healthcare Innovation /innovation Editors' Pick editors-pick Coronavirus Source Type: news
China Eases Covid-19 Travel Rules, But They Are Still Onerous
International visitors will still be required to jump through plenty of hoops.
Source: Forbes.com Healthcare News - November 11, 2022 Category: Pharmaceuticals Authors: Suzanne Rowan Kelleher, Forbes Staff Tags: Travel /travel Lifestyle /lifestyle Innovation /innovation Healthcare /healthcare Coronavirus suzannerowankelleherblog Source Type: news
Kineret authorized for emergency use by FDA for the treatment of COVID-19 related pneumonia
STOCKHOLM, Nov. 10, 2022. Sobi today announced that the US Food and Drug Administration has granted Emergency Use Authorization (EUA) for the use of Kineret® (anakinra) for the treatment of coronavirus disease 2019 (COVID-19) in hospitalized...
Source: Drugs.com - Clinical Trials - November 10, 2022 Category: Pharmaceuticals Source Type: clinical trials
Covid Reinfections May Boost Chances Of Death And Organ Failure, Study Finds — And The Risk Increases Each Time You Catch It
People with Covid reinfections were twice as likely to die and three times more likely to be hospitalized compared to people with just one infection, researchers found.
Source: Forbes.com Healthcare News - November 10, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Science /science Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
The Best Reason To Keep Up To Date With Boosters: Covid-19 Protection From Infection, Hospitalization And Death All Wane Over Time
Until the development of long-lasting, “universal” coronavirus vaccines, our best strategy for protection against infection, hospitalization, and death is staying up to date with our booster shots.
Source: Forbes.com Healthcare News - November 10, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
InnovationRx: Healthcare ’s Midterm Election Results And How The Omicron Booster Enhances Covid Protection
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - November 10, 2022 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Venture Capital /venture-capital Coronavirus Editors' Pick editors-pick Newsletter No Paywall no-paywall Source Type: news
Infants Less Likely Than Other Household Members to Get COVID-19
WEDNESDAY, Nov. 9, 2022 -- Infants whose mothers test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tend to develop less severe symptoms than their mothers or other members of their household and may not become infected...
Source: Drugs.com - Pharma News - November 9, 2022 Category: Pharmaceuticals Source Type: news
Expanding the WTO intellectual property waiver will hurt American jobs
The June decision by WTO members to waive commitments to protect intellectual property (IP) for COVID-19 vaccines under the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement was a political and ineffective measure thatdoes not address the true barriers to vaccine equity. Now, some are pushing to extend this harmful waiver to COVID-19 treatments, even though production exceeds demand for treatments, including for the most effective antivirals and monoclonal antibodies. Allowing foreign governments and competitors to disregard IP protections will result in a loss of American jobs and hamper much-needed American innovation.
Source: The Catalyst - November 9, 2022 Category: Pharmaceuticals Authors: Megan Van Etten Tags: Intellectual Property Coronavirus TRIPS Waiver Source Type: news
Paxlovid Associated With 26% Lower Long Covid Risk, Here Are The Study ’s Limitations Though
This study did have a number of limitations though.
Source: Forbes.com Healthcare News - November 8, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Coronavirus business pharma Source Type: news
Pfizer Says Updated Booster Shot Sparks Stronger Immune Response Versus Original Vaccine —As Uptake Slows Drastically
Protective antibodies against the dominant BA.5 omicron variant were “substantially higher” after the updated booster shot compared to the original formula, Pfizer and BioNTech said—but despite an expected Covid resurgence this winter, many Americans don’t plan on getting the shot.
Source: Forbes.com Healthcare News - November 4, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Deaths From Alcohol —On The Rise For Decades—Soared During Covid Pandemic, CDC Says
Deaths directly linked to alcohol use jumped 26% in the first year of the Covid-19 pandemic, according to a new CDC report, with rates rising sharply among younger men and women.
Source: Forbes.com Healthcare News - November 4, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Lifestyle /lifestyle Spirits /spirits Vices /vices Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news Coronavirus Source Type: news
